{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:54:56Z","timestamp":1777420496678,"version":"3.51.4"},"reference-count":74,"publisher":"SAGE Publications","issue":"11","license":[{"start":{"date-parts":[[2013,9,27]],"date-time":"2013-09-27T00:00:00Z","timestamp":1380240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Ann Pharmacother"],"published-print":{"date-parts":[[2013,11]]},"abstract":"<jats:p>\n                    <jats:bold>Background:<\/jats:bold>\n                    Pharmacy practice studies have been criticized for presenting poor intervention description, which has serious implications when attempting to replicate interventions elsewhere. Evidence of improved outcomes for patients with chronic kidney disease (CKD) following pharmacist intervention exist in the literature, but similar concerns with intervention description have been raised.\n                    <jats:bold>Objective:<\/jats:bold>\n                    To assess the implementability of evidence-based clinical pharmacist interventions in patients with CKD, based on the information contained in the published manuscripts.\n                    <jats:bold>Methods:<\/jats:bold>\n                    PubMed was searched to retrieve systematic reviews addressing the role of pharmacists in patients with CKD. Primary studies describing clinical pharmacy services in CKD were subsequently extracted. To describe and characterize pharmacists\u2019 interventions, the DEPICT (Descriptive Elements of Pharmacist Intervention Characterization Tool) was applied. Studies were independently classified as \u201cimplementable\u201d or \u201cnonimplementable\u201d by 2 authors, based on whether they could be easily implemented into practice using the description provided in the article. Finally, implementable interventions were grouped in different areas.\n                    <jats:bold>Results:<\/jats:bold>\n                    Five reviews were retrieved, and 39 original studies were analyzed. Of these, 59.0% were classified as nonimplementable. Among implementable interventions, 6 evidence-based areas of pharmacist interventions were identified: anemia, renal osteodystrophy, and cardiovascular risk factors management, medication appropriateness evaluation and medication reconciliation, patient education and compliance, and cost containment.\n                    <jats:bold>Conclusions:<\/jats:bold>\n                    Information contained in most articles reporting pharmacist interventions in CKD is not sufficient to ensure the implementation of the service in clinical practice. Pharmacy practice research articles should be written with the aim of improving clinical practice and not just showing the results of pharmacists\u2019 interventions.\n                  <\/jats:p>","DOI":"10.1177\/1060028013501802","type":"journal-article","created":{"date-parts":[[2014,7,15]],"date-time":"2014-07-15T13:56:59Z","timestamp":1405432619000},"page":"1498-1506","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":21,"title":["Assessing the Implementability of Clinical Pharmacist Interventions in Patients With Chronic Kidney Disease"],"prefix":"10.1177","volume":"47","author":[{"given":"Teresa M.","family":"Salgado","sequence":"first","affiliation":[{"name":"Research Institute for Medicines and Pharmaceutical Sciences (iMed.UL), University of Lisbon, Portugal"}]},{"given":"Cassyano J.","family":"Correr","sequence":"additional","affiliation":[{"name":"Departamento de Farm\u00e1cia, Universidade Federal do Paran\u00e1, Brazil"}]},{"given":"Rebekah","family":"Moles","sequence":"additional","affiliation":[{"name":"University of Sydney, NSW, Australia"}]},{"given":"Shalom I.","family":"Benrimoj","sequence":"additional","affiliation":[{"name":"Graduate School of Health, University of Technology Sydney, Australia"}]},{"given":"Fernando","family":"Fernandez-Llimos","sequence":"additional","affiliation":[{"name":"Research Institute for Medicines and Pharmaceutical Sciences (iMed.UL), Department of Social Pharmacy, University of Lisbon, Portugal"}]}],"member":"179","published-online":{"date-parts":[[2013,9,27]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0b013e3181e57962"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.168.7.687"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2011.399"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1K612"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S30244"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfr287"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2369-12-35"},{"key":"e_1_3_2_9_2","volume-title":"Implementation Research: A Synthesis of the Literature","author":"Fixsen DL","year":"2005","unstructured":"Fixsen DL, Naoom SF, Blase KA, Friedman RM, Wallace F. Implementation Research: A Synthesis of the Literature. Tampa, FL: University of South Florida, Louis de la Parte Florida Mental Health Institute, The National Implementation Research Network; 2005."},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.PHH.0000311888.06252.bb"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-006-0002-8"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2011.772"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-011-9592-0"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp090656"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1L302"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.17113"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1S006"},{"key":"e_1_3_2_18_2","unstructured":"US National Library of Medicine. Search strategy used to create the systematic reviews subset on PubMed. http:\/\/www.nlm.nih.gov\/bsd\/pubmed_subsets\/sysreviews_strategy.html. Accessed August 10 2012."},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-151-4-200908180-00135"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp10X502164"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijnurstu.2011.08.006"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2005.07.001"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.2307\/2529310"},{"key":"e_1_3_2_24_2","first-page":"871","article-title":"Evaluating the quality of patient education in a self-medication teaching program","volume":"18","author":"Thomas SG","year":"1983","unstructured":"Thomas SG, Diethelm AG, Keith TD, Simmons SM. Evaluating the quality of patient education in a self-medication teaching program. Hosp Formul. 1983;18:871-874, 877-878, 881-882 passim.","journal-title":"Hosp Formul"},{"key":"e_1_3_2_25_2","first-page":"725","article-title":"Pharmacist monitoring of drug therapy in patients with abnormal serum creatinine levels","volume":"28","author":"Golightly LK","year":"1993","unstructured":"Golightly LK, O\u2019Fallon CL, Moran WD, Sorocki AH. Pharmacist monitoring of drug therapy in patients with abnormal serum creatinine levels. Hosp Pharm. 1993;28:725-727, 730-732.","journal-title":"Hosp Pharm"},{"key":"e_1_3_2_26_2","first-page":"381","article-title":"Intervention of the service of hospital pharmacy for the rational use of erythropoietin: clinical and economic assessment of its dispensing and administration to hemodialyzed patients","volume":"20","author":"Soler Company E","year":"1996","unstructured":"Soler Company E, Faus Soler MT, Olivas Ferrandis JL, Cuenca Soria A, Sarrio Quiles L. Intervention of the service of hospital pharmacy for the rational use of erythropoietin: clinical and economic assessment of its dispensing and administration to hemodialyzed patients. Farm Hosp. 1996;20:381-386.","journal-title":"Farm Hosp"},{"key":"e_1_3_2_27_2","first-page":"1217","article-title":"Pharmacist-run program optimally manages secondary hyperparathyroidism","volume":"33","author":"Anonymous","year":"1998","unstructured":"Anonymous. Pharmacist-run program optimally manages secondary hyperparathyroidism. Hosp Formul. 1998;33:1217-1218.","journal-title":"Hosp Formul"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-0012.2000.140405.x"},{"key":"e_1_3_2_29_2","first-page":"169","article-title":"Cost avoidance and clinical benefits derived from a pharmacy-managed anemia program","volume":"36","author":"Quercia RA","year":"2001","unstructured":"Quercia RA, Abrahams R, White CM, D\u2019Avella J, Campbell M. Cost avoidance and clinical benefits derived from a pharmacy-managed anemia program. Hosp Pharm. 2001;36:169-175.","journal-title":"Hosp Pharm"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/58.21.2061"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2369-3-9"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.27.1831"},{"key":"e_1_3_2_33_2","first-page":"12","article-title":"Pharmacotherapy follow-up to transplanted patients during hospitalization in Foundation Clinic Valle del Lili (Cali-Colombia) [in Spanish]","volume":"2","author":"Salcedo J","year":"2004","unstructured":"Salcedo J, Agudelo N, Baena MI. Pharmacotherapy follow-up to transplanted patients during hospitalization in Foundation Clinic Valle del Lili (Cali-Colombia) [in Spanish]. Seguim Farmacoter. 2004;2:12-18.","journal-title":"Seguim Farmacoter"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2005.07.050"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1177\/001857870504001206"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-005-4800-4"},{"key":"e_1_3_2_37_2","first-page":"41","article-title":"Medication reconciliation in hemodialysis patients","volume":"18","author":"Ledger S","year":"2008","unstructured":"Ledger S, Choma G. Medication reconciliation in hemodialysis patients. CANNT J. 2008;18:41-43.","journal-title":"CANNT J"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.jrn.2008.05.003"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1M187"},{"key":"e_1_3_2_40_2","first-page":"459","article-title":"Effectiveness of clinical pharmacist interventions in a hemodialysis unit","volume":"15","author":"Tang I","year":"1993","unstructured":"Tang I, Vrahnos D, Hatoum H, Lau A. Effectiveness of clinical pharmacist interventions in a hemodialysis unit. Clin Ther. 1993;15:459-464; discussion 432.","journal-title":"Clin Ther"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1177\/106002809402800304"},{"key":"e_1_3_2_42_2","first-page":"117","article-title":"Evaluation of drug-related problems in an outpatient hemodialysis unit and the impact of a clinical pharmacist","volume":"47","author":"Grabe DW","year":"1997","unstructured":"Grabe DW, Low CL, Bailie GR, Eisele G. Evaluation of drug-related problems in an outpatient hemodialysis unit and the impact of a clinical pharmacist. Clin Nephrol. 1997;47:117-121.","journal-title":"Clin Nephrol"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/56.19.1961"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/57.21.1994"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-0012.2001.150505.x"},{"key":"e_1_3_2_46_2","first-page":"392","article-title":"Effect of clinical pharmacy services on the blood pressure of African-American renal transplant patients","volume":"12","author":"Chisholm MA","year":"2002","unstructured":"Chisholm MA, Mulloy LL, Jagadeesan M, Martin BC, DiPiro JT. Effect of clinical pharmacy services on the blood pressure of African-American renal transplant patients. Ethn Dis. 2002;12:392-397.","journal-title":"Ethn Dis"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1592\/phco.23.2.231.32079"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2369-4-10"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2003.50048"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1002\/jppr2003333199"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1E269"},{"key":"e_1_3_2_52_2","first-page":"26","article-title":"Outpatient erythropoietin administered through a protocol-driven, pharmacist-managed program may produce significant patient and economic benefits","volume":"20","author":"Bucaloiu ID","year":"2007","unstructured":"Bucaloiu ID, Akers G, Bermudez MC, . Outpatient erythropoietin administered through a protocol-driven, pharmacist-managed program may produce significant patient and economic benefits. Manag Care Interface. 2007;20:26-30.","journal-title":"Manag Care Interface"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp060634"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1592\/phco.27.5.734"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.4103\/0250-474X.33149"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2008.06.050"},{"key":"e_1_3_2_57_2","first-page":"25","article-title":"Implementation of a pharmacist medication review clinic for haemodialysis patients","volume":"122","author":"Mirkov S","year":"2009","unstructured":"Mirkov S. Implementation of a pharmacist medication review clinic for haemodialysis patients. N Z Med J. 2009;122:25-37.","journal-title":"N Z Med J"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1542-4758.2009.00328.x"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1592\/phco.29.12.1433"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.4321\/S1886-36552009000300009"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp070569"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9459(24)01999-5"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-11-15"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.18440"},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000336.pub2"},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1L700"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.19374"},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/aft045"},{"key":"e_1_3_2_69_2","volume-title":"Recommended Practices for Online Supplemental Journal Article Materials","author":"National Information Standards Organization","year":"2013","unstructured":"National Information Standards Organization. Recommended Practices for Online Supplemental Journal Article Materials. Baltimore, MD: National Information Standards Organization; 2013."},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2753.2010.01375.x"},{"key":"e_1_3_2_71_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39234.436528.3A"},{"key":"e_1_3_2_72_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38338.674583.AE"},{"key":"e_1_3_2_73_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2007.03071.x"},{"key":"e_1_3_2_74_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.323.7325.1340"},{"key":"e_1_3_2_75_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pec.2008.01.014"}],"container-title":["Annals of Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1060028013501802","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1060028013501802","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1060028013501802","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:14:22Z","timestamp":1777374862000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1060028013501802"}},"subtitle":["An Analysis of Systematic Reviews"],"short-title":[],"issued":{"date-parts":[[2013,9,27]]},"references-count":74,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["10.1177\/1060028013501802"],"URL":"https:\/\/doi.org\/10.1177\/1060028013501802","relation":{},"ISSN":["1060-0280","1542-6270"],"issn-type":[{"value":"1060-0280","type":"print"},{"value":"1542-6270","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,27]]}}}